Spots Global Cancer Trial Database for Study to Describe Treatment Patterns and Outcomes in EGFRm NSCLC Patients in Belgium
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Study to Describe Treatment Patterns and Outcomes in EGFRm NSCLC Patients in Belgium
Official Title: REtrospective, obserVational Study to Describe the Treatment Patterns and Outcomes of Epidermal Growth Factor Receptor Mutant (EGFRm) Locally Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC) Patients in Belgium
Study ID: NCT03761901
Conditions
Study Description
Brief Summary: This is a retrospective, observational, multicentre study to evaluate treatment patterns and outcomes of patients diagnosed with locally advanced or metastatic EGFRm NSCLC in Belgium
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Research Site, Antwerpen, , Belgium
Research Site, Bouge, , Belgium
Research Site, Brussels, , Belgium
Research Site, Bruxelles, , Belgium
Research Site, Charleroi, , Belgium
Research Site, Edegem, , Belgium
Research Site, Gent, , Belgium
Research Site, Hasselt, , Belgium
Research Site, Mechelen, , Belgium
Research Site, Mons, , Belgium
Research Site, Roeselare, , Belgium
Research Site, Sint-Niklaas, , Belgium
Research Site, Sint-Truiden, , Belgium
Research Site, Turnhout, , Belgium
Research Site, Yvoir, , Belgium
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
